세계 조직은행 시장 규모는 조사 기간 동안 연평균 8.5%의 견조한 성장세를 보일 것으로 예상됩니다.
지역별 인사이트
첨단 기술에 대한 접근성, 의료 체계의 확장, 북미의 조직 은행 발전을 촉진하는 금융 환경 등으로 인해 북미가 2022년 가장 큰 시장 점유율을 차지할 것으로 예상됩니다.
유럽 시장은 연구개발 운동 증가 등으로 인해 시장 점유율 2위를 차지할 것으로 예상됩니다. 이 지역의 장기 기증자 수 증가도 조직 은행의 발전을 촉진하고 있습니다.
아시아태평양 시장은 조사 기간 동안 6.90%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.
이 보고서는 세계 조직은행 시장을 조사 분석하여 시장 역학, 지역 및 부문 분석, 기업 프로파일 등의 정보를 제공합니다.
Tissue Banking Market is anticipated to register a healthy CAGR of 8.5% during the review period.
The rising predominance of constant sicknesses like malignant growth, coronary illness, and diabetes infection significantly influence all around the world as well as raises the interest for cutting edge treatment options for the treatment of persistent sickness. As rising gamble of constant sickness appears to be the best treatment elective for tissue banking. What's more, according to the American Malignant growth Society, around 1.9 million new instances of disease were analysed in the US. Moreover, coronary illness is considered as the main source of death for ladies and men. One individual kick the bucket like clockwork in the US from cardiovascular illness. Around 4,66,566 individuals experienced coronary illness in the US. Coronary illness costs the US around USD 239.9 billion consistently from 2018 to 2019. Hence, the rising commonness of coronary illness disease, and diabetes is expanding the interest in tissue banking so central participants are distinctly interested in the research and improvement movement for new item advancement which pushes the development of tissue banking.
The Tissue Banking Market segmentation, based on type, includes media and consumable, cryopreservation equipment, thawing equipment, quality control equipment, and others.
The Tissue Banking Market segmentation is based on tissue types that include heart valve, cornea, bone, skin, brain & spinal cord, and others.
The Tissue Banking Market segmentation is based on applications that include therapeutics, medical research, and others.
Regional Insights
North America represented the biggest market share in 2022 attributable to the North America is supposed to order the biggest market share because of the rising propensity of egg frozen in the US, accessibility of advance innovation, expanding medical care framework, created monetary condition boos the development of tissue banking in the North America region.
Europe tissue banking market is supposed to represent the second-biggest market share because of the development of the market are expanding mechanical turn of events and item advancement, rising research and improvement movement, expanding event of life threating sickness like coronary illness, malignant growth, and others. Moreover, expanding quantities of organ contributors across the region is driving the development of tissue banking.
The Asia-Pacific tissue banking market is anticipated to register a CAGR of 6.90% during the review period. This is because of expanding venture by unfamiliar organizations, colossal ongoing sickness populace, expanding entrance of frozen eggs are driving the development of tissue banking in the Asia-pacific region.
Latin America holds the significant market share in the middle east and Africa region because of the region's development is credited to a developing utilization of tissue banking, rising mindfulness about the organ gift for saving other life, developing new mechanical turn of events and advance clinical office across the region are help the development of tissue banking in region.
The key market players are Applied Biosystems, Custom Biogenic Systems (US), Invitrogen, Thermo Scientific, Fisher Scientific, Cesca Therapeutics, Inc. (US), Unity Lab Services, BioLife Solutions (US), Atlanta Biologics Pvt. Ltd. (US), Lifeline Scientific (US), BioCision, core dynamics GmbH (US), Taylor-Wharton (US), and Panasonic Holdings Corporation (Japan).
TABLE OF CONTENTS